Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 Mg/Kg Plus Ipilimumab 3 Mg/Kg Expansion Cohort Results
Journal of Clinical Oncology - United States
doi 10.1200/jco.19.00538
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2019
Authors
Publisher
American Society of Clinical Oncology (ASCO)